Skip to main content

Provation Appoints Dr. Lukasz Kowalczyk as Executive Medical Director, Accelerating Provider-Centric Innovation and AI Leadership in Healthcare

Provation proudly announces the appointment of Dr. Lukasz Kowalczyk as Executive Medical Director. A nationally recognized gastroenterologist and health tech innovator, Dr. Kowalczyk brings a powerful combination of clinical expertise, entrepreneurial vision, and AI leadership to Provation’s vision to be the global leader in innovative solutions that maximize healthcare quality and productivity.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023216022/en/

Dr. Lukasz Kowalczyk, New Executive Medical Director at Provation

Dr. Lukasz Kowalczyk, New Executive Medical Director at Provation

“We believe that true innovation begins with deep clinical insight and a passion for improving patient outcomes,” said Ankush Kaul, President of Provation. “Dr. Kowalczyk embodies this belief, and we are thrilled to welcome him to our team.”

Dr. Kowalczyk joins Provation with a proven track record in clinical excellence and AI-driven innovation. A graduate of the Mayo Clinic AI Accelerator and a member of the HIMSS AI Advisory Group, he is widely respected for his thought leadership in responsible, scalable AI adoption. His proprietary Clinical Enterprise Value Stack (CEVS) framework will guide Provation’s strategy to deliver measurable clinical and financial ROI.

With frontline experience as a practicing gastroenterologist and a history of successful health tech ventures, Dr. Kowalczyk brings a provider-centric lens to innovation. His leadership will ensure Provation’s solutions remain deeply aligned with real-world clinical workflows, empowering physicians, hospitals, and health systems with smarter, scalable technologies.

“Provation’s vision centers on designing with empathy, precision, and a deep understanding of provider needs,” said Dr. Kowalczyk. “I’m excited to help shape the future of healthcare technology in a way that truly reflects the realities of clinical practice.”

In his new role, Dr. Kowalczyk will represent Provation at leading industry conferences, medical societies, and advisory boards—having a voice in national and global conversations around clinical quality, interoperability, and the future of procedural care. His insights will inform product strategy, ensuring alignment with emerging standards, customer needs, and the evolving landscape of digital health innovation.

Backed by Fortive and built on over 30 years of enterprise strength, Provation is uniquely positioned to scale innovation across the healthcare continuum. Dr. Kowalczyk’s strategic clinical lens will help translate Provation’s capabilities into solutions that deliver lasting impact at the point of care.

About Provation

Provation is a leading healthcare software provider dedicated to empowering providers with innovative solutions that streamline clinical workflows in the Gastroenterology and Anesthesia specialties. Provation’s platforms are trusted by over 5,000 hospitals, surgery centers, and medical offices globally. With a purpose-driven approach, Provation continues to drive productivity and improve patient outcomes through advanced documentation and workflow solutions. For more information, visit provationmedical.com and follow us on Twitter, Facebook, and LinkedIn.

“Provation’s vision centers on designing with empathy, precision, and a deep understanding of provider needs. I’m excited to help shape the future of healthcare technology in a way that truly reflects the realities of clinical practice."

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  224.41
+3.32 (1.50%)
AAPL  263.46
+3.88 (1.49%)
AMD  252.36
+17.37 (7.39%)
BAC  52.53
+0.77 (1.50%)
GOOG  261.19
+7.47 (2.94%)
META  738.28
+4.28 (0.58%)
MSFT  525.16
+4.60 (0.88%)
NVDA  186.69
+4.53 (2.49%)
ORCL  284.40
+4.33 (1.55%)
TSLA  432.30
-16.68 (-3.72%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.